← Back to Directory

ARS Pharmaceuticals, Inc. (SPRY) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for ARS Pharmaceuticals, Inc. (SPRY).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $8.70

Daily Change: +$0.10 / 1.15%

Daily Range: $8.40 - $8.95

Market Cap: $856,964,672

Daily Volume: 1,128,836

Performance Metrics

1 Week: -4.43%

1 Month: 7.88%

3 Months: -13.00%

6 Months: -2.49%

1 Year: -35.06%

YTD: -25.92%

About ARS Pharmaceuticals, Inc. (SPRY)

Daily market data for ARS Pharmaceuticals, Inc. (SPRY). Current price: 8.70, daily change: +$0.10 / 1.15%. Market cap: 856,964,672. Performance 1-week and 52-week.

Company Details

Employees: 163

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Selected stocks

TAT Technologies Ltd. (TATT)

TJX Companies, Inc. (The) (TJX)

Arcos Dorados Holdings Inc. (ARCO)

Aspire Biopharma Holdings, Inc. (ASBP)

CBIZ, Inc. (CBZ)